Apotex Losartan Product Recall (2019-03-08) Mar 8, 2019 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength NL1429, NZ8846, NZ8847, NZ8845 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA F. APO-Losartan / HCTZ 100/25 mg Tablet Tablet DIN 02371251 Hydrochlorothiazide 25mg NL1441, NZ8848, NL1445, NZ8849, NZ8860 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA D. APO-Losartan / HCTZ 50/12.5 mg Tablet Tablet DIN 02371235 Hydrochlorothiazide 12.5mg NG2087, NL1421, NG2086, NL1422 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA E. APO-Losartan / HCTZ 100/12.5 mg Tablet Tablet DIN 02371243 Hydrochlorothiazide 12.5mg NK1254, NK1253 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA B. APO-Losartan 50mg Tablet Tablet DIN 02353504 Losartan potassium 50mg NL1461, NG2092, NH5932, NH5933, NL1460, NH5934 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA C. APO-Losartan 100mg Tablet Tablet DIN 02353512 Losartan potassium 100mg NL1453, NL1452 Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA A. APO-Losartan 25mg Tablet Tablet DIN 02379058 Losartan potassium 25mg
Recalled Products
APO-Losartan 25mg Tablet
APO-Losartan 50mg Tablet
APO-Losartan 100mg Tablet
APO-Losartan / HCTZ 50/12.5 mgTablet
APO-Losartan / HCTZ 100/12.5 mgTablet
APO-Losartan / HCTZ 100/25 mgTablet
Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as “NMBA”) above the acceptable level.